Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 Feb 1;345(Pt 3):453–458.

Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts.

M T Frost 1, B Halliwell 1, K P Moore 1
PMCID: PMC1220777  PMID: 10642501

Abstract

Measurement of nitrotyrosine in biological fluids and tissues is increasingly being used to monitor the production of reactive nitrogen species in vivo. The detection of nitrotyrosine in vivo has been reported with the use of a variety of methods including immunoassay, HPLC and GLC/MS. The validity of HPLC and immunoassays have been questioned with regard to their selectivity and sensitivity limits. In principle, the measurement of nitrotyrosine by GLC/MS permits a highly specific, highly sensitive and fully quantitative assay. The nitration of tyrosine under acidic conditions in the presence of nitrite is well documented. Derivatization for the full quantification of nitrotyrosine by using GLC/MS can lead to the artifactual nitration of tyrosine if performed under acidic conditions in the presence of nitrite. We describe a novel alkaline method for the hydrolysis and derivatization of nitrotyrosine and tyrosine, and demonstrate its applicability to the measurement of plasma concentrations of both free and protein-bound nitrotyrosine and tyrosine. A detection limit of 1 pg for nitrotyrosine and 100 pg for tyrosine has been achieved. Our method allows, for the first time, the analysis of free and protein-bound nitrotyrosine and tyrosine in biological samples. The plasma concentrations (means+/-S.E.M.) of free tyrosine and nitrotyrosine in eight normal subjects were 12+/-0.6 microg/ml and 14+/-0.7 ng/ml respectively. Plasma proteins contained tyrosine and nitrotyrosine at 60.7+/-1.7 microg/mg and 2.7+/-0.4 ng/mg respectively.

Full Text

The Full Text of this article is available as a PDF (141.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banks B. A., Ischiropoulos H., McClelland M., Ballard P. L., Ballard R. A. Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia. Pediatrics. 1998 May;101(5):870–874. doi: 10.1542/peds.101.5.870. [DOI] [PubMed] [Google Scholar]
  2. Bruijn L. I., Beal M. F., Becher M. W., Schulz J. B., Wong P. C., Price D. L., Cleveland D. W. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7606–7611. doi: 10.1073/pnas.94.14.7606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cross A. H., Manning P. T., Keeling R. M., Schmidt R. E., Misko T. P. Peroxynitrite formation within the central nervous system in active multiple sclerosis. J Neuroimmunol. 1998 Aug 1;88(1-2):45–56. doi: 10.1016/s0165-5728(98)00078-2. [DOI] [PubMed] [Google Scholar]
  4. Crowley J. R., Yarasheski K., Leeuwenburgh C., Turk J., Heinecke J. W. Isotope dilution mass spectrometric quantification of 3-nitrotyrosine in proteins and tissues is facilitated by reduction to 3-aminotyrosine. Anal Biochem. 1998 May 15;259(1):127–135. doi: 10.1006/abio.1998.2635. [DOI] [PubMed] [Google Scholar]
  5. Crowley J. R., Yarasheski K., Leeuwenburgh C., Turk J., Heinecke J. W. Isotope dilution mass spectrometric quantification of 3-nitrotyrosine in proteins and tissues is facilitated by reduction to 3-aminotyrosine. Anal Biochem. 1998 May 15;259(1):127–135. doi: 10.1006/abio.1998.2635. [DOI] [PubMed] [Google Scholar]
  6. Eiserich J. P., Estévez A. G., Bamberg T. V., Ye Y. Z., Chumley P. H., Beckman J. S., Freeman B. A. Microtubule dysfunction by posttranslational nitrotyrosination of alpha-tubulin: a nitric oxide-dependent mechanism of cellular injury. Proc Natl Acad Sci U S A. 1999 May 25;96(11):6365–6370. doi: 10.1073/pnas.96.11.6365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Eiserich J. P., Hristova M., Cross C. E., Jones A. D., Freeman B. A., Halliwell B., van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature. 1998 Jan 22;391(6665):393–397. doi: 10.1038/34923. [DOI] [PubMed] [Google Scholar]
  8. Hensley K., Maidt M. L., Yu Z., Sang H., Markesbery W. R., Floyd R. A. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci. 1998 Oct 15;18(20):8126–8132. doi: 10.1523/JNEUROSCI.18-20-08126.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hugli T. E., Moore S. Determination of the tryptophan content of proteins by ion exchange chromatography of alkaline hydrolysates. J Biol Chem. 1972 May 10;247(9):2828–2834. [PubMed] [Google Scholar]
  10. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys. 1998 Aug 1;356(1):1–11. doi: 10.1006/abbi.1998.0755. [DOI] [PubMed] [Google Scholar]
  11. Kamisaki Y., Wada K., Nakamoto K., Kishimoto Y., Kitano M., Itoh T. Sensitive determination of nitrotyrosine in human plasma by isocratic high-performance liquid chromatography. J Chromatogr B Biomed Appl. 1996 Oct 25;685(2):343–347. doi: 10.1016/s0378-4347(96)00202-2. [DOI] [PubMed] [Google Scholar]
  12. Kaur H., Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett. 1994 Aug 15;350(1):9–12. doi: 10.1016/0014-5793(94)00722-5. [DOI] [PubMed] [Google Scholar]
  13. Kaur H., Lyras L., Jenner P., Halliwell B. Artefacts in HPLC detection of 3-nitrotyrosine in human brain tissue. J Neurochem. 1998 May;70(5):2220–2223. doi: 10.1046/j.1471-4159.1998.70052220.x. [DOI] [PubMed] [Google Scholar]
  14. Khan J., Brennand D. M., Bradley N., Gao B., Bruckdorfer R., Jacobs M., Brennan D. M. 3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method. Biochem J. 1998 Mar 1;330(Pt 2):795–801. doi: 10.1042/bj3300795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Koppenol W. H., Moreno J. J., Pryor W. A., Ischiropoulos H., Beckman J. S. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol. 1992 Nov-Dec;5(6):834–842. doi: 10.1021/tx00030a017. [DOI] [PubMed] [Google Scholar]
  16. Leeuwenburgh C., Rasmussen J. E., Hsu F. F., Mueller D. M., Pennathur S., Heinecke J. W. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J Biol Chem. 1997 Feb 7;272(6):3520–3526. doi: 10.1074/jbc.272.6.3520. [DOI] [PubMed] [Google Scholar]
  17. Liu H., Huang T., Kissinger C. B., Kissinger P. T. Comparison of detection methods for liquid chromatographic determination of 3-nitro-L-tyrosine. J Chromatogr B Biomed Sci Appl. 1998 Aug 25;713(2):289–295. doi: 10.1016/s0378-4347(98)00167-4. [DOI] [PubMed] [Google Scholar]
  18. Oldreive C., Zhao K., Paganga G., Halliwell B., Rice-Evans C. Inhibition of nitrous acid-dependent tyrosine nitration and DNA base deamination by flavonoids and other phenolic compounds. Chem Res Toxicol. 1998 Dec;11(12):1574–1579. doi: 10.1021/tx980163p. [DOI] [PubMed] [Google Scholar]
  19. Petruzzelli S., Puntoni R., Mimotti P., Pulerà N., Baliva F., Fornai E., Giuntini C. Plasma 3-nitrotyrosine in cigarette smokers. Am J Respir Crit Care Med. 1997 Dec;156(6):1902–1907. doi: 10.1164/ajrccm.156.6.9702075. [DOI] [PubMed] [Google Scholar]
  20. Roggensack A. M., Zhang Y., Davidge S. T. Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension. 1999 Jan;33(1):83–89. doi: 10.1161/01.hyp.33.1.83. [DOI] [PubMed] [Google Scholar]
  21. Shigenaga M. K., Lee H. H., Blount B. C., Christen S., Shigeno E. T., Yip H., Ames B. N. Inflammation and NO(X)-induced nitration: assay for 3-nitrotyrosine by HPLC with electrochemical detection. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3211–3216. doi: 10.1073/pnas.94.7.3211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Skinner K. A., Crow J. P., Skinner H. B., Chandler R. T., Thompson J. A., Parks D. A. Free and protein-associated nitrotyrosine formation following rat liver preservation and transplantation. Arch Biochem Biophys. 1997 Jun 15;342(2):282–288. doi: 10.1006/abbi.1997.0114. [DOI] [PubMed] [Google Scholar]
  23. Sodum R. S., Fiala E. S. Amination of tyrosine in liver cytosol protein of male F344 rats treated with 2-nitropropane, 2-nitrobutane, 3-nitropentane, or acetoxime. Chem Res Toxicol. 1997 Dec;10(12):1420–1426. doi: 10.1021/tx970137b. [DOI] [PubMed] [Google Scholar]
  24. ter Steege J. C., Koster-Kamphuis L., van Straaten E. A., Forget P. P., Buurman W. A. Nitrotyrosine in plasma of celiac disease patients as detected by a new sandwich ELISA. Free Radic Biol Med. 1998 Nov 15;25(8):953–963. doi: 10.1016/s0891-5849(98)00184-1. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES